| Previous Close | 71.17 |
| Open | 71.12 |
| Bid | 0.00 x |
| Ask | 0.00 x |
| Day's Range | 70.63 - 71.56 |
| 52 Week Range | 56.20 - 76.80 |
| Volume | 1,786,036 |
| Avg. Volume | 1,850,515 |
| Market Cap | 25.41B |
| Beta | 0.28 |
| PE Ratio (TTM) | 36.13 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 3.10 (4.36%) |
| Ex-Dividend Date | 2017-06-02 |
| 1y Target Est | N/A |
- Zacks•16 days ago
Ventas to Gain from Life Science Real Estate Investments
University-based life science real estate is a new zone of investment that has caught attention and Ventas Inc. (VTR) has, by now, committed roughly $2 billion to this segment.
Capital Cube•24 days agoVentas, Inc. : VTR-US: Dividend Analysis : June 06th, 2017 (record date) : By the numbers : June 5, 2017
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Ventas, Inc. with the following peers – Healthcare Trust of America, Inc. Class A, HCP, Inc., Welltower, Inc., Duke Realty Corporation, Tiptree Inc. Class A, Physicians Realty Trust, Universal Health Realty Income Trust, Sabra Health Care REIT, Inc. and Brookdale Senior Living Inc. (HTA-US, HCP-US, ... Read more (Read more...)
Zacks•29 days agoWhy Is Ventas (VTR) Up 3.8% Since the Last Earnings Report?
Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
